Characterization of immune checkpoint inhibitor-associated fulminant type 1 diabetes associated with autoantibody status and ethnic origin

OBJECTIVE: Fulminant type 1 diabetes may uniquely occur as a fatal adverse event during immune checkpoint inhibitor (ICI) therapy. We investigated the clinical and immunological characteristics of ICI-associated fulminant type 1 diabetes (IFD). RESEARCH DESIGN AND METHODS: We enrolled 80 patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Junlin, Luo, Shuoming, Yin, Wenfeng, Guo, Keyu, Xiang, Yufei, Li, Xia, Liu, Zhenqi, Zhou, Zhiguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702060/
https://www.ncbi.nlm.nih.gov/pubmed/36451831
http://dx.doi.org/10.3389/fimmu.2022.968798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702060/
https://www.ncbi.nlm.nih.gov/pubmed/36451831
http://dx.doi.org/10.3389/fimmu.2022.968798

Ejemplares similares